Dr. Rahul Gupta Releases Statement on DOJ’s New Drug Enforcement Actions April 14, 2023 • Press Releases
Biden-Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States April 12, 2023 • Press Releases
Biden-Harris Administration Launches Campaign to Raise Awareness About the Dangers of Fentanyl and the Life-Saving Effects of Naloxone in Partnership with the Ad Council April 06, 2023 • Press Releases
Dr. Gupta Applauds FDA Announcement to Make First Naloxone Product Available Over-the-Counter March 29, 2023 • Press Releases
RELEASE: Dr. Rahul Gupta Releases Statement on CDC’s New Overdose Death Data March 16, 2023 • Press Releases
White House Announces Over $275 Million For Law Enforcement Officials Working to Disrupt Drug Trafficking and Dismantle Illicit Finance Operations March 16, 2023 • Press Releases
Remarks as Prepared for Delivery by Dr. Rahul Gupta – the U.S. National Statement for the 66th Session of the Commission on Narcotic Drugs in Vienna, Austria March 13, 2023 • Speeches and Remarks
President Biden Calls for Historic Funding to Beat the Overdose Epidemic Being Driven by Fentanyl March 09, 2023 • Press Releases
ONDCP Director Dr. Rahul Gupta Statement on DEA’s Move to Ensure Patients Can Continue to Begin Treatment for Opioid Use Disorder via Telehealth February 24, 2023 • Press Releases
In New Jersey, ONDCP Director Dr. Rahul Gupta Discusses How Biden-Harris Administration Is Expanding Access to Addiction Treatment in Jails and Prisons February 24, 2023 • Press Releases
